![Roland Kolbeck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 145 140 $ per 2026-08-31
Dr. Roland Kolbeck is a Chief Scientific Officer at Aclaris Therapeutics, Inc. Dr. Kolbeck was previously employed as a Chief Scientific Officer by Spirovant Sciences, Inc. He received his graduate degree from the University of Regensburg.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-01 | 23 990 ( 0,02 % ) | 145 140 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-07-28 |
| Företag | Position | Slut |
|---|---|---|
Spirovant Sciences, Inc.
 Spirovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing of pharmaceuticals related to gene therapy | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
University of Regensburg
 University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spirovant Sciences, Inc.
Spirovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing of pharmaceuticals related to gene therapy | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
